A large randomized clinical study named the “IRESSA Pan-Asian Study (IPASS)” has reported that high rates of mutations in the EGFR gene were observed in female NSCLC patients without smoking experience [35]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.